StockData
Akari Therapeutics Plc logo

Akari Therapeutics Plc (AKTX) stock

AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$6.65+0.95 (+16.67%)

Close on Nov 18, 2026Market cap $12.95MP/E –Yield –

Akari Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Akari Therapeutics's total debt was $200.00K at Sep 30, 2024.

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024$200.00K–
Q2 FY2024Jun 30, 2024$600.00K–
Q1 FY2024Mar 31, 2024$900.00K–

More Akari Therapeutics figures

See a number that looks wrong?